CFLT vs KLRS
Confluent Inc (CFLT) versus Kalaris Therapeutics, Inc. (KLRS) — a side-by-side from cached financials, not a winner call.
Confluent Inc (CFLT) is a software - infrastructure company listed on US.
Kalaris Therapeutics, Inc. (KLRS) is a biotechnology company listed on US.
Latest reported CFLT revenue for 2024-12-31 was $963.6M. Net income was -$345.1M. Revenue was up 24.0% from 2023-12-31 to 2024-12-31. CFLT currently screens at market cap $11.13B.
KLRS does not have a complete income-statement cache yet.
CFLT currently screens at market cap $11.13B. KLRS currently screens at market cap $0.
Not investment advice. Open the CFLT and KLRS stock pages for the full models.
Not investment advice.